Pharmacokinetics Of Tropifexor, A Potent Farnesoid X Receptor Agonist, Are Similar In Subjects With Mild, Moderate, And Severe Hepatic Impairment: Results From A Multi-Centre, Open-Label, Single-Dose Study
JOURNAL OF HEPATOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要